Related Experiment Video
Updated: Sep 12, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
The YY1-ABCB7 regulatory Axis is associated with malignant progression and ferroptosis sensitivity in lung
Liang Zhang1, Hailong Wang1, Gaofeng Liang2
1Department of Respiratory Medicine, The Affiliated LiHuiLi Hospital of Ningbo University, 57 Xingning Road, Yinzhou District, Ningbo City, 315000, Zhejiang Province, China.
Aim:
Ferroptosis, a newly identified form of regulated cell death, has emerged as a promising therapeutic target in cancer treatment. The study was to clarify the regulatory effects of Yin Yang 1 (YY1) on ATP Binding Cassette Subfamily B Member 7 (ABCB7) expression and its related functions in lung adenocarcinoma (LUAD), focusing on ferroptosis.
Methods:
The bioinformatics analysis of ABCB7 expression in LUAD was initially conducted using public databases and subsequently validated through the examination of LUAD tissue samples. The effects of ABCB7 knockdown and YY1 overexpression on LUAD cell proliferation, migration, invasion, and sensitivity to ferroptosis were evaluated using a series of in vitro assays.
Results:
Elevated expression of ABCB7 in lung adenocarcinoma (LUAD) was significantly associated with poorer patient survival rates. Silencing of ABCB7 led to a marked reduction in LUAD cell proliferation, migration, and invasion, while concurrently inducing ferroptosis. Moreover, overexpression of YY1 was found to partially reverse these biological effects. Mechanistic investigations revealed that YY1 targets and activates the ABCB7 promoter, a conclusion supported by dual-luciferase assays. In vivo studies further confirmed that knockdown of ABCB7 inhibited LUAD cell proliferation and increased susceptibility to ferroptosis.
Conclusion:
Our research suggests that YY1-mediated activation of ABCB7 may contribute to LUAD progression and potentially influences ferroptosis susceptibility. Targeting the YY1-ABCB7 axis emerges as a potential novel therapeutic approach for LUAD management.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
02:23Abnormal Proliferation
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:22PI3K/mTOR/AKT Signaling Pathway
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...